THURMAN JOSHUA M.,TAUBE CHRISTIAN,GELFAND ERWN W.,GILKENSON GARY STEVEN,HOLERS VERNON MICHAEL
申请号：
IN4916/DELNP/2006
公开号：
IN256899B
申请日:
2006.08.25
申请国别(地区):
IN
年份:
2013
代理人:
摘要：
Disclosed are novel inhibitors of the alternative complement pathway and particularly, novel anti-factor B antibodies. Also disclosed is the use of such inhibitors to reduce or prevent airway hyperresponsiveness and/or airway inflammation by selectively inhibiting the alternative complement pathway, thereby treating diseases in which such conditions play a role. Also disclosed is the use of such inhibitors to reduce or prevent other diseases and conditions, including ischemia-reperfusion injury, by inhibition of the alternative complement pathway.
